Wednesday, February 27, 2013

• GILEAD SCIENCES INC Files SEC form 10-K, Annual ReportEDGAR Online (Wed, Feb 27)
• GlaxoSmithKline unit joins patent pool for AIDS drugsat Reuters (Wed, Feb 27)

Tuesday, February 26, 2013

• 2 Value BioPharmacetuicals for Your Portfolioat Motley Fool (Tue, Feb 26)
• 3 Solid, Low Beta Biotechnology Stocks To Buy On Dipat Seeking Alpha (Tue, Feb 26)
• Is Gilead Sciences Destined for Greatness?at Motley Fool (Tue, Feb 26)
• Google Among 5 Top Stocks Flexing Relative Strengthat Investor's Business Daily (Tue, Feb 26)

Monday, February 25, 2013

• Gilead Sciences to Present at Two Upcoming Investor ConferencesBusiness Wire (Mon, Feb 25)
• Agrium Pullback Viewed as Buying Opportunity and 4 Stock Analyses to See Nowat Wall St. Cheat Sheet (Mon, Feb 25)
• Gilead Stock Hits New 52-Week High (GILD)at TheStreet (Mon, Feb 25)
• 2 Stocks To Buy, 2 Stocks To Sell, What's Next For The Marketat Seeking Alpha (Mon, Feb 25)

Sunday, February 24, 2013

• This Week in Biotechat Motley Fool (Sun, Feb 24)
• Five Stocks That Give You Biologic Solutionsat Seeking Alpha (Sun, Feb 24)

Friday, February 22, 2013

• 3 Humongous Health-Care Stocks This Weekat Motley Fool (Fri, Feb 22)
• Gilead Sciences Inc (GILD): Today's Featured Health Care Winnerat TheStreet (Fri, Feb 22)
• Are Big Pharma's CEO Pay Packages Outrageous?at Motley Fool (Fri, Feb 22)
• Obamacare Boosts Health Sectorat TheStreet (Fri, Feb 22)

Thursday, February 21, 2013

• Aches And Pains Shouldn't Obscure Achillion's Potentialat Seeking Alpha (Thu, Feb 21)
• Regulators Await Gilead's Hep C Candidateat Seeking Alpha (Thu, Feb 21)
• Gilead, Teva Agree to End Patent Feudat Motley Fool (Thu, Feb 21)
• FDA Whiplashes This Biotechat Motley Fool (Thu, Feb 21)
• Gilead and Teva Bury the HatchetZacks (Thu, Feb 21)
• Don't Tune Out; Pharmacyclics' Move Higher Isn't Over Yetat Seeking Alpha (Thu, Feb 21)
• The Zacks Analyst Blog Highlights: Toyota Motor, General Motors, Volkswagen, Honda Motor and Gilead SciencesZacks (Thu, Feb 21)
• Monsanto, Gilead, TWX, Autodesk: Intellectual Propertyat Bloomberg (Thu, Feb 21)

Wednesday, February 20, 2013

• InterMune Sale Looms as Lung Drug Nears FDA Nod: Real M&Aat Bloomberg (Wed, Feb 20)

Add GILD News to My Yahoo!